Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for

Posts Tagged ‘Is AZN A Good Stock To Buy Right Now?’

Biopharmaceutical, Bio-technology

FDA Sends Complete Response Letter To AstraZeneca PLC (ADR) (AZN) Following Rejection Of Hyperkalemia Drug

AstraZeneca PLC (ADR) (NYSE:AZN) has acknowledged the receipt of the Complete Response Letter (CRL) from the U.S. Food and Drug Administration for ZS...

Keep Reading →

March 21 - News, Stock Analysis - Comments

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, drugstore, service,

AstraZeneca PLC (ADR) (AZN) In Respiratory Drug Deal With Circassia Pharmaceuticals

In an effort to enhance collaboration with Circassia Pharmaceuticals, AstraZeneca PLC (ADR) (NYSE:AZN) has acquired an equity stake valued at $50 million...

Keep Reading →

March 20 - News, Stock Analysis - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

AstraZeneca PLC (ADR) (AZN)’s Lynparza Trial Results Positive In Competitive Threat To Clovis Oncology Inc (CLVS) And TESARO Inc (TSRO)

Lynparza, an ovarian cancer treatment developed by AstraZeneca PLC (ADR) (NYSE:AZN) has demonstrated its ability to slow down disease progression. AstraZeneca...

Keep Reading →

March 16 - News, Stock Analysis - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Here’s What Just Happened With AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO) And Clovis Oncology Inc (CLVS)

It’s been a big week for PARP inhibitors. AstraZeneca PLC (ADR) (NYSE:AZN) just put out data from a phase 3 investigation of its lead PARP asset Lynparza...

Keep Reading →

March 15 - News, Stock Analysis - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

AstraZeneca PLC (ADR) (AZN) Rejected Drugs To Be Reconsidered

AstraZeneca plc (ADR) (NYSE:AZN) is reconsidering some of its rejected drugs, as they could possess potential in curing a disease they were not initially...

Keep Reading →

March 14 - News, Stock Analysis - Comments

Biopharmaceutical, Bio-technology

China MediTech And AstraZeneca PLC (ADR) (AZN) To Present Savolitinib Phase II Results At The Genitourinary Cancers Symposium 2017

Hutchison China MediTech Limited and AstraZeneca plc (ADR) (NYSE:AZN) are to present data from their phase II clinical trials of Savolitinib, at the upcoming...

Keep Reading →

February 15 - News, Stock Analysis - Comments

biotech, shares, market, amgen, percent, technical, economy, pharmaceutical, rate, quote, producer, drag, business, bio, capitalization, tech, biotechnology, sector, gain,,

Clovis Oncology Inc (CLVS)’s Ovarian Cancer Drug Faces Stiff Competition From AstraZeneca PLC (ADR) (AZN), TESARO Inc (TSRO)

Trials of rival drugs from AstraZeneca PLC (ADR) (NYSE:AZN) and TESARO Inc (NASDAQ:TSRO) will determine the adoption of the PARP inhibitor, Rubraca from...

Keep Reading →

January 31 - News, Stock Analysis - Comments

10 Pharmacist Shortage Countries in Need of Pharmacists in 2017

AstraZeneca PLC (ADR) (AZN) Wins A Six Months Paediatric Exclusivity Approval Of Its Symbicort

The US Food and Drug Administration (FDA) has confirmed that Symbicort (budesonide/formoterol) Inhalation Aerosol is worth being granted paediatric exclusivity...

Keep Reading →

January 30 - News, Stock Analysis - Comments

gene, dna, organism, microarray, health, green, life, human genome, biotechnology, genetic diseases, disease, molecular biology, modern medical, micro structure,

AstraZeneca PLC (ADR) (AZN) Planning Tagrisso Label Expansion To Shore Up Earnings

AstraZeneca plc (ADR) (NYSE:AZN) share price could receive a major boost on the company pursuing a label expansion for its blockbuster Tagrisso. The drug...

Keep Reading →

January 3 - News, Stock Analysis - Comments

gene, dna, organism, microarray, health, green, life, human genome, biotechnology, genetic diseases, disease, molecular biology, modern medical, micro structure,

AstraZeneca plc (ADR) (AZN) CEO Claims The Drug Approval Process Of NHS Is Counterproductive

AstraZeneca plc (ADR) (NYSE:AZN)’s chief executive officer has said that the long negotiation process that the NHS undertakes with drugmakers before...

Keep Reading →

December 30 - News, Stock Analysis - Comments

gene, dna, organism, microarray, health, green, life, human genome, biotechnology, genetic diseases, disease, molecular biology, modern medical, micro structure,

AstraZeneca PLC (ADR) (AZN) Cuts Jobs, Signs New Collaboration With Eli Lilly And Co (LLY)

AstraZeneca plc (ADR) (NYSE:AZN) has recently unveiled how it plans to transform its US Commercial segment as part of its broader growth strategy. “...

Keep Reading →

December 9 - News, Stock Analysis - Comments

dna, bio, clone, helix, medical, health, research, cell, gene, microscopic, render, tech, chemistry, molecular, liquid, life, biotechnology, technology, medicine, molecule,

Can AstraZeneca Plc (AZN) Lung Cancer Pill Take Over Chemo Treatment?

Tagrisso, a lung cancer med from AstraZeneca plc (ADR) (NYSE:AZN) is already in early approval based on mid-stage studies, which demonstrates the possibility...

Keep Reading →

December 7 - News, Stock Analysis - Comments

gene, dna, organism, microarray, health, green, life, human genome, biotechnology, genetic diseases, disease, molecular biology, modern medical, micro structure,

AstraZeneca PLC (ADR) (AZN) Relocating Jobs At U.K. Division

AstraZeneca plc (ADR) (NYSE:AZN) plans to cut some back office jobs in the U.K. as the company works toward cost-cutting and operation consolidation....

Keep Reading →

December 6 - News, Stock Analysis - Comments

court, courtroom, gavel, american, flag, legal, desk, background, legally, juror, guilt, chair, table, divorce, judgment, nobody, mallet, tool, brown, decisions, symbol,

AstraZeneca PLC (ADR) (AZN), Ranbaxy Laboratories Limited (ADR) (RBXLY) Wins Over Illegal Deal Case

The 1st US Circuit Court of Appeals has recently ruled in favor of AstraZeneca plc (ADR) (NYSE:AZN) and Ranbaxy Laboratories Limited (ADR) (OTCMKTS:RBXLY...

Keep Reading →

November 23 - News, Stock Analysis - Comments

test, cancer, researcher, research, dna, bio, clean, modern, chemistry, human, white, medical, sample, pipette, life, culture, laboratory, biotechnology, genetic, disease,

AstraZeneca PLC (ADR) (AZN) Retreats On Some Durvalumab Plans

AstraZeneca PLC (ADR) (NYSE:AZN) will no longer seek early regulatory review of its drug candidate durvalumab in patients with head and neck cancers....

Keep Reading →

November 11 - Earnings Report, News, Stock Analysis - Comments

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

AstraZeneca PLC (ADR) (AZN) Unveils Positive SOLO-2 Data

AstraZeneca plc (ADR) (NYSE:AZN) has recently released encouraging data from SOLO-2, a phase 3 clinical trial evaluating the efficacy of Lynparza (olaparib...

Keep Reading →

October 27 - News, Stock Analysis - Comments

Abbvie ABBV biopharmaceuticals cell blood dna gene stem test biotech research

AstraZeneca Plc (ADR) (AZN) Offloads Two Diabetes Drugs to Focus on Core Therapeutic Areas

AstraZeneca Plc (ADR) (NYSE:AZN) has once again reiterated its intention to focus on core therapeutic areas with the signing of a new commercialization...

Keep Reading →

October 14 - News, Stock Analysis - Comments

Insider Monkey Small Cap Strategy
Lists

12 Biggest Chinese Software Companies

15 Biggest Real Estate Companies in the World

12 Largest Oil Tanker Companies in the World

12 Countries That Produce the Most Cars

15 Largest Canadian Companies

15 Biggest Companies That Use AWS

15 Biggest Private Equity Firms in the World

15 Biggest VR Companies in the World

20 VERY Witty Tinder Bios that Are Guaranteed to Get a Right Swipe Right

15 Largest Global IPOs of All Time

12 Biggest Companies with Gay CEOs

15 Good Excuses to Not Go to School for Strict Parents

Top 5 Good Excuses to Not Go to School for Strict Parents

15 Biggest Water Treatment Companies in the World

15 Biggest Companies That Don’t Pay Dividends

How Amazon Makes Money

15 Cheapest Online Shopping Sites in USA

Top 20 Biggest Black Owned Companies in the US

15 Most Popular Instant Messaging Apps

15 Biggest Companies That have been Hacked

15 Biggest Hosting Companies in the World

15 Largest Industrial Companies In The US

10 Best Solar Energy Stocks to Buy Now

13 Biggest Gay Pride Parades in the World

25 Biggest Questions in Life

15 Biggest Oil Refining Companies in the World

20 Biggest One Hit Wonders

15 Biggest Petrochemical Companies in the World

15 Biggest Paper Companies in the World

15 Biggest Vaccine Companies in the World

10 Biggest Newspapers In The US

15 Longest Pipelines in the US

15 Largest Food Companies in the World

20 Biggest Questions in Science

15 Biggest Wholesale Companies in the World

15 Biggest Robotics Companies in the World

5 Easiest Vegetable Oils to Make at Home

25 Largest Lakes in the US

15 Biggest Companies That Aren’t Profitable

15 Biggest Semiconductor Companies in the World

15 Biggest Malls in the US

10 Biggest Waste Management Companies in the World

15 Biggest Travel Companies in the World: When Will They Recover Their 2020 Losses?

15 Biggest Media Companies in the World

11 Easiest Countries to Adopt a Baby

Top 5 Easiest Countries to Adopt a Baby

15 Largest IT Services Companies in the World

15 Largest Medical Device Companies in the World

15 Biggest Companies That Don’t Pay Taxes

15 Biggest Public Companies in the World in 2021
Home Hedge Funds Markets Blog Site Map
Authors About Us Contact Us Privacy Policy Terms of Use CCPA - Do Not Sell My Information
All text and design is copyright ©2021 Koala Guide LLC. All rights reserved.